Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0C4VN
|
|||
| Former ID |
DIB015908
|
|||
| Drug Name |
GM3 ganglioside vaccine
|
|||
| Synonyms |
Breast tumor vaccine, Center of Molecular Immunology; GM3 ganglioside vaccine, Center of Molecular Immunology; Melanoma vaccine, Center of Molecular Immunology; GM3 ganglioside vaccine (breast cancer), Center of Molecular Immunology; GM3 ganglioside vaccine (breast tumor), Center of Molecular Immunology; GM3 ganglioside vaccine (melanoma), Center of Molecular Immunology; GM3 ganglioside vaccine (NGcGM3/VSSP), Center of Molecular Immunology; N-Acetyl-GM3/VSSP ISA-51
Click to Show/Hide
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65] | Phase 3 | [1] | |
| Company |
The Center of Molecular Immunology
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo. Melanoma Res. 2001 Jun;11(3):219-27. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.